Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE BY PRIMARY INSIDER IN HBC
October 01, 2021 10:21 ET
|
Hofseth Biocare ASA
James Berger, Chief Commercial Officer in Hofseth BioCare ASA, has today 01.10.2021 purchased 30,000 shares through his wholly-owned company Nevera AG, at an average price of NOK 6,65 per share. ...
Hofseth Biocare ASA: HBC ONBOARDS EX-NOVARTIS AND EX-PFIZER SENIOR REGULATORY AFFAIRS PROFESSIONAL, DR ZUBAIR HUSSAIN
September 22, 2021 02:15 ET
|
Hofseth Biocare ASA
HBC is delighted to announce the appointment of Dr Zubair Hussain as Senior Regulatory Consultant from September 2021. Dr Hussain has over 25 years’ experience in Regulatory Affairs and has held...
Hofseth Biocare ASA: HBC HIRES EX DKSH SENIOR EXECUTIVE DR TANJA SCHAFFER, TO HEAD UP ITS GLOBAL INGREDIENTS BUSINESS AND AS CEO OF HBC SWITZERLAND GMBH
September 17, 2021 02:02 ET
|
Hofseth Biocare ASA
HBC is delighted to announce the hiring of Dr Tanja Schaffer as Executive Vice President for HBC’s Global Ingredients division and as CEO of HBC's new Swiss subsidiary HBC Switzerland GmbH. The...
Hofseth Biocare ASA: MANDATORY NOTIFICATION OF TRADE
August 30, 2021 07:21 ET
|
Hofseth Biocare ASA
Roger Hofseth has today, 30 August 2021, bought 50,000 shares at an average price of NOK 7.2867 per share. Roger Hofseth is CEO and primary insider of Hofseth BioCare ASA. After the transaction, Mr....
Hofseth Biocare ASA: SECOND QUARTER 2021 FINANCIAL REPORT
August 27, 2021 02:10 ET
|
Hofseth Biocare ASA
This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading Act Hofseth BioCare ASA (“HBC”) had net sales revenues of NOK 31.0m (19.9m) in...
Hofseth Biocare ASA: PRIMARY INSIDER NOTIFICATION
May 25, 2021 04:22 ET
|
Hofseth Biocare ASA
Christoph Baldegger, primary insider and member of the Board of Directors in Hofseth BioCare ASA («HBC») has today purchased 50,000 shares in HBC at an average price of NOK 7.7295 per share. As a...
Hofseth Biocare ASA: FIRST QUARTER 2021 FINANCIAL REPORT
May 21, 2021 02:44 ET
|
Hofseth Biocare ASA
HBC had net sales revenues of NOK 16.8m (10.4m) in the first quarter and gross operating revenues of NOK 16.8m (18.5m). Gross revenues in first quarter 2020 included NOK 8.2m in insurance claim...
Hofseth Biocare ASA: GLOBAL INNOVATION PARTNERSHIP WITH CATALENT TO DEVELOP DELAYED-RELEASE FORMULATION OF OMEGO FISH OIL
May 12, 2021 02:45 ET
|
Hofseth Biocare ASA
ÅLESUND, NORWAY – May 12, 2021 — Hofseth BioCare ASA (HBC), a Norwegian biotech company that develops high-value ingredients and finished products, today announced that it has begun a global...
Hofseth Biocare ASA: COMPLETED ANNUAL GENERAL MEETING
April 23, 2021 08:03 ET
|
Hofseth Biocare ASA
The AGM in Hofseth BioCare ASA was held in Havnegata 11, Ålesund today on Friday 23 April 2021. All the matters were decided according to the proposals in the notice. Please find the minutes from the...
Hofseth Biocare ASA: IMCD AND HBC EXTEND INTERNATIONAL AGREEMENT TO INCLUDE EUROPE
April 15, 2021 02:00 ET
|
Hofseth Biocare ASA
European Biotech and consumer health company HBC has confirmed plans to extend an exclusive distribution agreement for its marine branded products with leading speciality chemicals and ingredients...